

Is Accutane still in shortage in 2026? Get the latest update on Isotretinoin availability, pricing, and what patients can do to find it in stock.
If you're on Isotretinoin — or about to start a course — you've probably heard the question: "Is Accutane in shortage?" The answer is complicated, and it depends on what you mean by "shortage."
Let's cut through the confusion and give you the facts about Isotretinoin availability in 2026, why it's hard to find, what it costs, and what you can do about it.
As of early 2026, Isotretinoin is not listed on the FDA's official drug shortage list. That means the federal government has not declared a formal nationwide shortage of this medication.
However, that doesn't match what many patients are experiencing on the ground. Across the country, patients report:
So while there isn't a formal "shortage" in the traditional sense, there's a very real access problem — and if you're the patient stuck without your medication, the distinction doesn't matter much.
Several factors contribute to the difficulty of finding Isotretinoin in stock:
Isotretinoin is distributed through the iPLEDGE REMS program — the most restrictive medication access program in the country. Every prescription requires monthly verification, lab work, and (for patients who can become pregnant) a pregnancy test. You then have exactly 7 days to pick up your medication.
This system means pharmacies can't stockpile Isotretinoin. They order conservatively, often only when they know a patient is coming. If there's any hiccup in the supply chain, the patient misses their window.
Isotretinoin is made by several generic manufacturers, including Teva (Claravis), Mylan (Amnesteem), Zydus (Zenatane), and Sun Pharma (Absorica). At any given time, one or more manufacturers may have production delays, quality holds, or raw material issues — creating spotty availability for specific dose strengths.
Most retail pharmacies carry a limited selection of Isotretinoin strengths. If your dose is 35 mg or 25 mg — less common than 20 mg or 40 mg — your pharmacy may not carry it at all and will need to special-order it.
Even when the medication is physically available, insurance delays can prevent you from filling it. Prior authorization requirements, step therapy protocols, and formulary restrictions all add time to the process.
For a deeper dive into these factors, read why Accutane is so hard to find in 2026.
Cost is a major concern for Isotretinoin patients, especially those without insurance or with high-deductible plans:
Remember, a typical Isotretinoin course lasts 5 to 6 months, so total out-of-pocket costs can add up quickly. For detailed savings strategies, check out our guide on how to save money on Accutane in 2026.
A few developments worth noting:
Here's your action plan:
For step-by-step guidance, read our complete guide: how to find Accutane in stock near you.
The Isotretinoin "shortage" in 2026 isn't a traditional drug shortage — it's a combination of supply chain quirks, regulatory hurdles, and pharmacy stocking decisions that make it genuinely hard for patients to access their medication. But with the right tools and a proactive approach, you can navigate it.
Stay informed, plan ahead each month, and use Medfinder to stay on top of availability. If Isotretinoin truly isn't accessible for you right now, talk to your dermatologist about alternative treatments that can help bridge the gap.
You focus on staying healthy. We'll handle the rest.
Try Medfinder Concierge FreeMedfinder's mission is to ensure every patient gets access to the medications they need. We believe this begins with trustworthy information. Our core values guide everything we do, including the standards that shape the accuracy, transparency, and quality of our content. We’re committed to delivering information that’s evidence-based, regularly updated, and easy to understand. For more details on our editorial process, see here.